BusinessPfizer Analyzing The Sales About $15 Million Consumer Health Business
Pfizer said on Tuesday Pfizer analyzing the sales or spin-off of its consumer health business, an operation that could be worth about $15 million. The announcement was made when Germany’s Merck KGaA is also looking to sell its non-prescription drug business, including brands such as the Seven Seas vitamins, which...